Eventide Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $20.1M | Hold |
|
|||||
|
2019
Q4 | $44.2M | Hold |
|
|||||
|
2019
Q3 | $43.3M | Buy |
|
|||||
|
2019
Q2 | $48.9M | Buy |
|
|||||
|
2019
Q1 | $20.7M | Buy |
|
|||||
|
2018
Q4 | $10.3M | Hold |
|
|||||
|
2018
Q3 | $18M | Hold |
|
|||||
|
2018
Q2 | $17.4M | Hold |
|
|||||
|
2018
Q1 | $16.6M | Hold |
|
|||||
|
2017
Q4 | $16.9M | Hold |
|
|||||
|
2017
Q3 | $12.1M | Hold |
|
|||||
|
2017
Q2 | $9.99M | Hold |
|
|||||
|
2017
Q1 | $9.29M | Buy |
|
|||||
|
2016
Q4 | $9.11M | Hold |
|
|||||
|
2016
Q3 | $9.22M | Hold |
|
|||||
|
2016
Q2 | $5.76M | Hold |
|
|||||
|
2016
Q1 | $3.97M | Hold |
|
|||||
|
2015
Q4 | $5.37M | Buy |
|
|||||
|
2015
Q3 | $6.49M | Buy |
|
|||||
|
2015
Q2 | $8.29M | Buy |
|
|||||
|
2015
Q1 | $8.97M | Buy |
|
|||||
|
2014
Q4 | $10.2M | Buy |
|
|||||
|
2014
Q3 | $7.22M | Buy |
|
|||||
|
2014
Q2 | $8.21M | Buy |
|
|||||
|
2014
Q1 | $7.38M | Buy |
|
|||||
|
2013
Q4 | $4.08M | Buy |
|